Titan Pharmaceuticals Inc.
TTNP | NASDAQ
$2.34
-$0.30 (-11.36%)
At close: Dec 16, 2025, 1:46 PM ET
TTM Period Ending | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 | Q4 2020 Dec 31, 2020 | Q3 2020 Sep 30, 2020 | Q2 2020 Jun 30, 2020 | Q1 2020 Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | 10K | 10K | 10K | 10K | 81K | 85K | 86K | 184K | 154K | 154K | 303K | 397K | 481K | 741K | 1.04M | 1.53M | 2.45M | 3.3M | 4.18M | 4.84M | 5M | 4.83M | 4M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | 3K | 30K | 472K | 515K | 512K | 1.42M | 1.03M | 1.04M | 1.09M | 1.35M | 1.39M | 1.45M | 3.44M | 2.93M | 3.07M | 3.13M | 1.63M | 1.14M | 1.16M |
Gross Profit | n/a | 5K | 5K | 2K | n/a | 73K | 50K | -388K | -331K | -358K | -1.26M | -723K | -638K | -607K | -608K | -351K | 81K | -989K | 377K | 1.12M | 1.71M | 3.37M | 3.69M | 2.85M |
Operating Income | -2.42M | -2.63M | -2.61M | -4.03M | -4.56M | -5.82M | -7.13M | -6.64M | -7.28M | -7.96M | -8.54M | -9.39M | -10.24M | -10.11M | -9.38M | -9.26M | -9.35M | -933K | -3.7M | -5.76M | -7.35M | -17.08M | -16.29M | -16.79M |
Interest Income | n/a | -1K | -1K | -1K | n/a | 1K | 1K | 8K | 29K | 56K | 77K | 75K | 53K | 29K | 8K | 3K | 3K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -2.49M | -2.85M | -2.81M | -4.21M | -4.71M | -5.89M | -5.46M | -4.95M | -5.57M | -6.17M | -8.47M | -9.34M | -10.21M | -10.18M | -9.46M | -8.68M | -8.78M | 1.51M | 2.21M | -753K | -3.7M | -15.39M | -16.97M | -17.53M |
Net Income | -2.49M | -2.85M | -2.81M | -4.21M | -4.71M | -5.89M | -5.46M | -4.95M | -5.55M | -6.14M | -8.44M | -9.34M | -10.23M | -10.2M | -9.48M | -8.68M | -8.78M | -9.32M | -12.34M | -15.3M | -18.24M | -19.1M | -16.97M | -17.53M |
Selling & General & Admin | 2.42M | 2.63M | 2.61M | 4.03M | 4.56M | 5.33M | 6.22M | 5.37M | 5.55M | 5.39M | 5.56M | 5.95M | 6.04M | 6.39M | 5.57M | 4.98M | 4.99M | -995K | 1.58M | 4.01M | 5.8M | 12.73M | 12.2M | 11.96M |
Research & Development | n/a | n/a | n/a | n/a | n/a | 487K | 911K | 1.35M | 1.91M | 2.87M | 3.38M | 3.91M | 4.76M | 4.29M | 4.55M | 5.22M | 5.69M | 4.79M | 5.16M | 5.52M | 5.92M | 7.72M | 7.78M | 7.68M |
Other Expenses | n/a | n/a | n/a | n/a | 2K | 2K | 4K | -1K | -101K | -171K | -189K | -209K | -112K | -96K | -87K | -78K | -85K | 1.92M | 1.91M | 1.92M | 1.93M | 20K | 18K | 28K |
Operating Expenses | 2.42M | 2.63M | 2.61M | 4.03M | 4.56M | 5.82M | 7.12M | 6.64M | 7.28M | 8.01M | 8.6M | 9.6M | 10.63M | 10.59M | 10.12M | 10.21M | 10.68M | 3.79M | 6.73M | 9.53M | 11.72M | 20.44M | 19.98M | 19.63M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 33K | 44K | 44K | 44K | 11K | n/a | n/a | 1K | 1K | 1K | 2K | 2K | 53K | 299K | 548K | 769K | 948K | 940K | 943K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -2K | -5K | -5K | -5K | -3K | n/a | n/a | n/a | n/a | -2.01M | -2.01M | -2.01M | -2.01M | n/a | n/a | n/a | 1.83M | 1.83M | 1.83M | 1.83M |
Cost & Expenses | 2.42M | 2.63M | 2.61M | 4.03M | 4.56M | 5.82M | 7.13M | 6.64M | 7.28M | 8.01M | 8.6M | 9.6M | 10.63M | 10.59M | 10.12M | 10.3M | 10.88M | 3.38M | 7M | 9.94M | 12.19M | 22.08M | 21.11M | 20.79M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 234K | 477K | 486K | 486K | 252K | 9K |
Shares Outstanding (Basic) | 1K | 1.4M | 1.07M | 914K | 899K | 914K | 914K | 853K | 781.5K | 750.8K | 750.8K | 750.8K | 711.25K | 731.45K | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 3.26M | 3.17M | 2.76M |
Shares Outstanding (Diluted) | 1K | 1.4M | 1.07M | 914K | 899K | 914K | 914K | 853K | 781.5K | 750.8K | 750.8K | 750.8K | 711.25K | 731.45K | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 3.26M | 3.17M | 2.76M |
EPS (Basic) | -431.84 | -2.72 | -2.98 | -4.62 | -5.24 | -6.88 | -6.50 | -6.32 | -7.28 | -8.37 | -11.53 | -10.66 | -9.73 | -7.39 | -4.74 | -4.34 | -4.39 | -4.66 | -5.21 | -5.84 | -6.55 | -6.44 | -10.35 | -20.36 |
EPS (Diluted) | -431.84 | -2.72 | -2.98 | -4.62 | -5.24 | -6.88 | -6.50 | -6.32 | -7.28 | -8.37 | -11.53 | -10.66 | -9.73 | -7.39 | -4.74 | -4.34 | -4.39 | -4.66 | -5.21 | -5.84 | -6.55 | -6.44 | -10.35 | -20.36 |
EBITDA | -2.44M | -2.66M | -2.61M | -4.03M | -4.55M | -5.81M | -7.09M | -6.57M | -7.17M | -7.8M | -8.36M | -9.21M | -10.04M | -10.54M | -9.8M | -9.67M | -9.77M | 1.16M | -1.57M | -3.63M | -4.1M | -15.61M | -13.53M | -14.09M |
EBIT | -2.44M | -2.66M | -2.61M | -4.03M | -4.56M | -5.82M | -7.13M | -6.64M | -7.28M | -7.96M | -8.54M | -9.39M | -10.24M | -10.74M | -10.01M | -9.89M | -9.99M | 928K | -1.85M | -3.92M | -4.39M | -15.9M | -13.78M | -14.33M |
Depreciation & Amortization | 2.5K | 2.5K | 2.5K | 4.25K | 5K | 8K | 35K | 71K | 112K | 154K | 175K | 187K | 196K | 204K | 212K | 218K | 221K | 233K | 276K | 285K | 292K | 285K | 249K | 246K |
Add to Watchlist
Select watchlists to add or remove TTNP